How to Apply for IPS 2022 — Vaccine Manufacturing Units Scheme (Up to ₹13 Cr)

The scheme documentation does not publish a detailed scoring matrix or name the approving committee, so the assessment pathway described for this sub-scheme is as follows.

• Eligibility screening: applications are first checked against the basic conditions — whether the applicant is a new or existing enterprise, whether the investment falls within the Gross Fixed Capital Investment definition, whether the term loan has been sanctioned by a bank or financial institution as per RBI guidelines, and whether the application was filed inside the permitted window.
• Committee review: applications that clear the screening are then taken up by a committee that includes representatives of the Department of Industries, and potentially other bodies of the UT administration.
• Assessment on merit: the committee weighs the proposed investment, the enterprise's commitment to production and employment, and how far the project advances the UT's industrial objectives in the vaccine manufacturing sector.
• Approval: sanction goes to enterprises that follow the scheme guidelines closely and are expected to deliver a significant economic impact.

Approval is therefore tied to both compliance and the economic case a unit presents, not to a first-come-first-served queue.